{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T20:58:26Z","timestamp":1762376306168,"version":"3.41.2"},"reference-count":51,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2017.00782","type":"journal-article","created":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T07:20:21Z","timestamp":1509520821000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Atheroregressive Potential of the Treatment with a Chimeric Monoclonal Antibody against Sulfated Glycosaminoglycans on Pre-existing Lesions in Apolipoprotein E-Deficient Mice"],"prefix":"10.3389","volume":"8","author":[{"given":"Victor","family":"Brito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katia","family":"Mellal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karina F.","family":"Zoccal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosdel","family":"Soto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liliane","family":"M\u00e9nard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger","family":"Sarduy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia H.","family":"Faccioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huy","family":"Ong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana M.","family":"V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie","family":"Marleau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2017,11,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.clim.2009.07.002","article-title":"Adaptive immunity and atherosclerosis.","volume":"134","author":"Andersson","year":"2010","journal-title":"Clin. Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.atherosclerosis.2012.10.074","article-title":"Emerging biomarkers and intervention targets for immune-modulation of atherosclerosis - a review of the experimental evidence.","volume":"227","author":"Bjorkbacka","year":"2013","journal-title":"Atherosclerosis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1172\/JCI2265","article-title":"Identification of the principal proteoglycan-binding site in LDL. A single-point mutation in apo-B100 severely affects proteoglycan interaction without affecting LDL receptor binding.","volume":"101","author":"Boren","year":"1998","journal-title":"J. Clin. Invest."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1161\/ATVBAHA.112.300444","article-title":"Induction of anti-anti-idiotype antibodies against sulfated glycosaminoglycans reduces atherosclerosis in apolipoprotein E-deficient mice.","volume":"32","author":"Brito","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"4766","DOI":"10.1074\/jbc.275.7.4766","article-title":"Oxidized low density lipoproteins regulate synthesis of monkey aortic smooth muscle cell proteoglycans that have enhanced native low density lipoprotein binding properties.","volume":"275","author":"Chang","year":"2000","journal-title":"J. Biol. Chem."},{"key":"B6","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.freeradbiomed.2015.08.027","article-title":"Arresting progressive atherosclerosis by immunization with an anti-glycosaminoglycan monoclonal antibody in apolipoprotein E-deficient mice.","volume":"89","author":"Delgado-Roche","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1161\/ATVBAHA.108.173344","article-title":"Acid sphingomyelinase promotes lipoprotein retention within early atheromata and accelerates lesion progression.","volume":"28","author":"Devlin","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.atherosclerosis.2016.07.011","article-title":"Irgm1 promotes M1 but not M2 macrophage polarization in atherosclerosis pathogenesis and development.","volume":"251","author":"Fang","year":"2016","journal-title":"Atherosclerosis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1172\/JCI9259","article-title":"Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice.","volume":"105","author":"Febbraio","year":"2000","journal-title":"J. Clin. Invest."},{"key":"B10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.aogh.2013.12.001","article-title":"Regression of atherosclerosis: insights from animal and clinical studies.","volume":"80","author":"Feig","year":"2014","journal-title":"Ann. Glob. Health"},{"key":"B11","doi-asserted-by":"publisher","first-page":"196","DOI":"10.2174\/138945008783755557","article-title":"Atheroprotective effects of HDL: beyond reverse cholesterol transport.","volume":"9","author":"Feig","year":"2008","journal-title":"Curr. Drug Targets"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.numecd.2011.09.007","article-title":"Retention of atherogenic lipoproteins in the artery wall and its role in atherogenesis.","volume":"22","author":"Fogelstrand","year":"2012","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.ajpath.2015.12.023","article-title":"IL-19 halts progression of atherosclerotic plaque, polarizes, and increases cholesterol uptake and efflux in macrophages.","volume":"186","author":"Gabunia","year":"2016","journal-title":"Am. J. Pathol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00281-013-0402-8","article-title":"Immunological aspects of atherosclerosis.","volume":"36","author":"Garrido-Urbani","year":"2014","journal-title":"Semin. Immunopathol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1161\/ATVBAHA.111.237693","article-title":"Animal models of atherosclerosis.","volume":"32","author":"Getz","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1161\/CIRCRESAHA.107.149666","article-title":"Retention of low-density lipoprotein in atherosclerotic lesions of the mouse: evidence for a role of lipoprotein lipase.","volume":"101","author":"Gustafsson","year":"2007","journal-title":"Circ. Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/ni.2001","article-title":"The immune system in atherosclerosis.","volume":"12","author":"Hansson","year":"2011","journal-title":"Nat. Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/S0735-1097(02)02135-6","article-title":"Oral tolerance with heat shock protein 65 attenuates Mycobacterium tuberculosis-induced and high-fat-diet-driven atherosclerotic lesions.","volume":"40","author":"Harats","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"736","DOI":"10.5551\/jat.12534","article-title":"Regression of atherosclerosis in apolipoprotein E-deficient mice is feasible using high-dose angiotensin receptor blocker, candesartan.","volume":"19","author":"Hayashi","year":"2012","journal-title":"J. Atheroscler. Thromb."},{"key":"B20","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1161\/ATVBAHA.111.242800","article-title":"Regulatory T-cell response to apolipoprotein B100-derived peptides reduces the development and progression of atherosclerosis in mice.","volume":"32","author":"Herbin","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/cvr\/cvu002","article-title":"Regression of atherosclerosis with anti-CD3 antibody via augmenting a regulatory T-cell response in mice.","volume":"102","author":"Kita","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1093\/cvr\/cvn120","article-title":"Cytokines and atherosclerosis: a comprehensive review of studies in mice.","volume":"79","author":"Kleemann","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1161\/ATVBAHA.109.202671","article-title":"Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosis.","volume":"30","author":"Klingenberg","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1172\/JCI13005","article-title":"VCAM-1 is critical in atherosclerosis.","volume":"107","author":"Ley","year":"2001","journal-title":"J. Clin. Invest."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.immuni.2013.06.009","article-title":"Immune effector mechanisms implicated in atherosclerosis: from mice to humans.","volume":"38","author":"Libby","year":"2013","journal-title":"Immunity"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1161\/CIRCRESAHA.114.302699","article-title":"Inflammation and its resolution as determinants of acute coronary syndromes.","volume":"114","author":"Libby","year":"2014","journal-title":"Circ. Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"11779","DOI":"10.1073\/pnas.0403259101","article-title":"Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques.","volume":"101","author":"Llodra","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B28","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0021-9150(99)00390-1","article-title":"Macrophage-released proteoglycans enhance LDL aggregation: studies in aorta from apolipoprotein E-deficient mice.","volume":"150","author":"Maor","year":"2000","journal-title":"Atherosclerosis"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1161\/ATVBAHA.111.229443","article-title":"Orally administered eicosapentaenoic acid induces rapid regression of atherosclerosis via modulating the phenotype of dendritic cells in LDL receptor-deficient mice.","volume":"31","author":"Nakajima","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1161\/01.ATV.14.1.133","article-title":"ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree.","volume":"14","author":"Nakashima","year":"1994","journal-title":"Arterioscler. Thromb."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1172\/JCI43802","article-title":"Suppressed monocyte recruitment drives macrophage removal from atherosclerotic plaques of Apoe-\/- mice during disease regression.","volume":"121","author":"Potteaux","year":"2011","journal-title":"J. Clin. Invest."},{"key":"B32","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1161\/01.ATV.0000152613.83243.12","article-title":"Apolipoprotein E promotes the regression of atherosclerosis independently of lowering plasma cholesterol levels.","volume":"25","author":"Raffai","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1161\/CIRCRESAHA.114.301174","article-title":"Mechanisms that regulate macrophage burden in atherosclerosis.","volume":"114","author":"Randolph","year":"2014","journal-title":"Circ. Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1067\/mva.2001.115963","article-title":"Dramatic remodeling of advanced atherosclerotic plaques of the apolipoprotein E-deficient mouse in a novel transplantation model.","volume":"34","author":"Reis","year":"2001","journal-title":"J. Vasc. Surg."},{"key":"B35","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.atherosclerosis.2015.12.022","article-title":"Dyslipidemia-associated alterations in B cell subpopulation frequency and phenotype during experimental atherosclerosis.","volume":"247","author":"Rinc\u00f3n-Ar\u00e9valo","year":"2016","journal-title":"Atherosclerosis"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/srep29353","article-title":"Adaptive immunity against gut microbiota enhances apoE-mediated immune regulation and reduces atherosclerosis and western-diet-related inflammation.","volume":"6","author":"Saita","year":"2016","journal-title":"Sci. Rep."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1161\/CIRCRESAHA.108.182063","article-title":"Infusion of reconstituted high-density lipoprotein leads to acute changes in human atherosclerotic plaque.","volume":"103","author":"Shaw","year":"2008","journal-title":"Circ. Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/nature00804","article-title":"Subendothelial retention of atherogenic lipoproteins in early atherosclerosis.","volume":"417","author":"Skalen","year":"2002","journal-title":"Nature"},{"key":"B39","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1161\/ATVBAHA.111.238659","article-title":"Antiatherosclerotic effect of an antibody that binds to extracellular matrix glycosaminoglycans.","volume":"32","author":"Soto","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.4161\/mabs.29970","article-title":"Targeting arterial wall sulfated glycosaminoglycans in rabbit atherosclerosis with a mouse\/human chimeric antibody.","volume":"6","author":"Soto","year":"2014","journal-title":"MAbs"},{"key":"B41","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nri2675","article-title":"Macrophage death and defective inflammation resolution in atherosclerosis.","volume":"10","author":"Tabas","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1161\/CIRCRESAHA.115.306256","article-title":"Macrophage phenotype and function in different stages of atherosclerosis.","volume":"118","author":"Tabas","year":"2016","journal-title":"Circ. Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1083\/jcb.201412052","article-title":"Recent insights into the cellular biology of atherosclerosis.","volume":"209","author":"Tabas","year":"2015","journal-title":"J. Cell Biol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1161\/CIRCULATIONAHA.106.676890","article-title":"Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications.","volume":"116","author":"Tabas","year":"2007","journal-title":"Circulation"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1161\/01.ATV.0000139313.69015.1c","article-title":"Serial studies of mouse atherosclerosis by in vivo magnetic resonance imaging detect lesion regression after correction of dyslipidemia.","volume":"24","author":"Trogan","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"3781","DOI":"10.1073\/pnas.0511043103","article-title":"Gene expression changes in foam cells and the role of chemokine receptor CCR7 during atherosclerosis regression in ApoE-deficient mice.","volume":"103","author":"Trogan","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1161\/CIRCULATIONAHA.106.615609","article-title":"Induction of oral tolerance to oxidized low-density lipoprotein ameliorates atherosclerosis.","volume":"114","author":"van Puijvelde","year":"2006","journal-title":"Circulation"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1161\/01.RES.0000126921.29919.51","article-title":"Proteoglycans in atherosclerosis and restenosis: key roles for versican.","volume":"94","author":"Wight","year":"2004","journal-title":"Circ. Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/ncpcardio1086","article-title":"Rapid regression of atherosclerosis: insights from the clinical and experimental literature.","volume":"5","author":"Williams","year":"2008","journal-title":"Nat. Clin. Pract. Cardiovasc. Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1161\/01.ATV.15.5.551","article-title":"The response-to-retention hypothesis of early atherogenesis.","volume":"15","author":"Williams","year":"1995","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aad6100","article-title":"Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming.","volume":"8","author":"Zimmer","year":"2016","journal-title":"Sci. Transl. Med."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2017.00782\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T07:20:24Z","timestamp":1509520824000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2017.00782\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,1]]},"references-count":51,"alternative-id":["10.3389\/fphar.2017.00782"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2017.00782","relation":{},"ISSN":["1663-9812"],"issn-type":[{"type":"electronic","value":"1663-9812"}],"subject":[],"published":{"date-parts":[[2017,11,1]]},"article-number":"782"}}